Scientific Programme & Abstracts from the International Meeting in Pediatric Endocrinology (IMPE)

impe0096fc10.3 | Miscellaneous | IMPE2023

Pediatric hypercalcemia in a tertiary center

Lucía Feller Ana , Aziz Mariana , Vaiani Elisa , Ciaccio Marta , Lorena Viterbo Gisela

Introduction: Pediatric hypercalcemia is a rare condition. It occurs due to an imbalance between the endocrine system (PTH, calcitriol) and its target organs (bone, kidney and intestine). It is produced by multiple causes. Although it is usually asymptomatic, sometimes it could become an emergency, with increased morbidity and/or mortality.Objective: To describe etiologies, biochemical profiles, clinical characteristics ...

impe0096p31 | Bone, Growth Plate and Mineral Metabolism | IMPE2023

PTH resistance in a patient with 2q37 deletion syndrome and Albright hereditary osteodystrophy phenotype

Aziz Mariana , Lincolns Mendoza Muñoz Ronald , Gazek Natalia , Vaiani Elisa , Ciaccio Marta , Sanchez Eduardo , Huckstadt Victoria , Viterbo Gisela

Background: 2q37 deletion syndrome is a rare chromosomal abnormality (OMIM #600430) also called brachydactyly mental retardation syndrome (BDMR), or Albright Hereditary Osteodystrophy-like syndrome (AHO). It is characterized by a wide spectrum of clinical findings including mild to moderate psychomotor developmental delay/intellectual disability, brachydactyly type E, short stature, obesity, hypotonia, characteristic facial dysmorphism, hypermobility /joint di...

impe0096p154 | Thyroid | IMPE2023

Hypothyroidism secondary to steroid-resistant nephrotic syndrome in children

Martínez Castillo Iratxe , Vaiani Elisa , Aziz Mariana , Dujovne Noelia , Gazek Natalia , Adragna Marta , López Laura , Ciaccio Marta , Gil Silvia

Introduction: Children with steroid-resistant nephrotic syndrome (SRNS) are at high risk of developing hypothyroidism due to the urinary loss of serum (s) thyroid hormone-binding proteins, thyroxine (T4) and triiodothyronine (T3). There are limited data on the variability in thyroid hormone profiles and replacement doses in pediatric SRNS.Aims: To analyze the thyroid hormone profile in pediatric patients with SRNS under ...

impe0096ep17 | Bone, Growth Plate and Mineral Metabolism | IMPE2023

Hypercalcemia Under Treatment with Recombinant Human Growth Hormone (rGH) in A Male Patient with Familial Hypocalciuric Hypercalcemia (FHH)

del Carmen Malosetti María , Garciarena Martín , Marino Roxana , Perez Garrido Natalia , Soledad Rubaja María , Pozo Guzmán Favio , Elisa Vaiani

Introduction: FHH is an autosomal dominant disorder caused by an inactivating mutation of the CaSR gene in two-thirds of cases. It is considered a "benign"and generally asymptomatic condition. On the other hand, GH and IGF1 stimulate renal synthesis of 1,25-hydroxyvitamin D and increase bone turnover.Case Report: We present a 9.8-year-old (y) male, referred for growth assessment. He was born at 36 weeks with no...

impe0096p136 | Sex Differentiation, Gonads and Gynaecology, and Sex Endocrinology | IMPE2023

Differences of Sex Development Associated to Asymmetrical Overgrowth in a Patient with Chromosomal Mosaicism.

Quarracino Malena , Terada Claudia , Daroqui Manuel , Baialardo Edgardo , Ramirez Pablo , Perez Garrido Natalia , Marino Roxana , Miglieta Aldo , Caino Silvia , Moresco Angelica , Gabriela Obregon Maria , Belgorosky Alicia , Alonso Cristina , Berensztein Esperanza , Vaiani Elisa

Differences of sex development (DSD) with asymmetrical overgrowth is a very rare condition that can be secondary to a chromosomal mosaicism (ChM). ChM is usually a post zygote event and arises when two or more cell lines with different chromosomal constitutions are present in the same individual. Usually distinctive methodologies approaches are required to reach the diagnosis. Our objective is to describe a patient with asymmetrical overgrowth and DSD and the methodological st...